<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="0" ids="16990">Bilirubin</z:chebi> is generated from the breakdown of <z:chebi fb="4" ids="30413">heme</z:chebi> by <z:chebi fb="4" ids="30413">heme</z:chebi> oxygenase and the reduction of <z:chebi fb="0" ids="17033">biliverdin</z:chebi> by the enzyme <z:chebi fb="0" ids="17033">biliverdin</z:chebi> reductase </plain></SENT>
<SENT sid="1" pm="."><plain>Several large population studies have reported a significant inverse correlation between plasma <z:chebi fb="0" ids="16990">bilirubin</z:chebi> levels and the incidence of <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Protection from <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e> is also observed in patients with <z:e sem="disease" ids="C0017551" disease_type="Disease or Syndrome" abbrv="">Gilbert's syndrome</z:e> which is a disease characterized by mutations in hepatic UGT1A1, the enzyme responsible for the conjugation of <z:chebi fb="0" ids="16990">bilirubin</z:chebi> into the bile </plain></SENT>
<SENT sid="3" pm="."><plain>Despite the strong correlation between plasma <z:chebi fb="0" ids="16990">bilirubin</z:chebi> levels and the protection from <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e>, the mechanism by which increases in plasma <z:chebi fb="0" ids="16990">bilirubin</z:chebi> acts to protect against <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e> is unknown </plain></SENT>
<SENT sid="4" pm="."><plain>Since the <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:chebi fb="0" ids="35674">antihypertensive</z:chebi> actions of <z:chebi fb="0" ids="16990">bilirubin</z:chebi> are likely due to its renal actions, the effects of moderate increases in plasma <z:chebi fb="0" ids="16990">bilirubin</z:chebi> on renal hemodynamics as well as <z:chebi fb="0" ids="16990">bilirubin</z:chebi>'s potential effects on renal tubule function will be discussed in this review </plain></SENT>
<SENT sid="5" pm="."><plain>Mechanisms of action as well as the potential for <z:chebi fb="0" ids="35674">antihypertensive</z:chebi> therapies targeting moderate increases in plasma <z:chebi fb="0" ids="16990">bilirubin</z:chebi> levels will also be highlighted </plain></SENT>
</text></document>